Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

Harrison's Principles of Internal Medicine.

1988 • 11,687 citations

Leishmaniasis

1999 • 1,190 citations

Harrison's Principles of Internal Medicine

1984 • 1,158 citations

Drug development for neglected diseases: a deficient market and a public-health policy failure

2002 • 853 citations

Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years

1997 • 804 citations

Leishmania and human immunodeficiency virus coinfection: the first 10 years

1997 • 719 citations

Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic

2000 • 633 citations

Leishmaniasis

1996 • 591 citations

Drug resistance in Indian visceral leishmaniasis

2001 • 575 citations

The global burden of disease in 1990: summary results, sensitivity analysis and future directions.

1994 • 521 citations

Miltefosine, an Oral Agent, for the Treatment of Indian Visceral Leishmaniasis

1999 • 463 citations

Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani

1999 • 357 citations

Rapid accurate field diagnosis of Indian visceral leishmaniasis

1998 • 256 citations

Trial of oral miltefosine for visceral leishmaniasis

1998 • 242 citations

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan

2000 • 237 citations

Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis

2001 • 231 citations

Epidemiology of visceral leishmaniasis in India.

1999 • 231 citations

The Epidemic of Visceral Leishmaniasis in Western Upper Nile, Southern Sudan: Course and Impact from 1984 to 1994

1996 • 219 citations

Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan

2001 • 207 citations

Human leishmaniases: epidemiology and public health aspects.

1992 • 198 citations

Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial

1994 • 194 citations

Development of a Species-Specific PCR Assay for Detection of Leishmania donovani in Clinical Samples from Patients with Kala-Azar and Post-Kala-Azar Dermal Leishmaniasis

2001 • 192 citations

A policy for leishmaniasis with respect to the prevention and control of drug resistance

2001 • 176 citations

Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India Commentary: Some good news for treatment of visceral leishmaniasis in Bihar

1998 • 172 citations

Malnutrition as a Risk Factor for Severe Visceral Leishmaniasis

1987 • 170 citations

Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial Commentary: cost and resistance remain issues

2001 • 169 citations

Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.

1998 • 167 citations

Electrocardiographic changes during Treatment of Leishmaniasis with Pentavalent Antimony (Sodium Stibogluconate) *

1985 • 167 citations

The Reemergence of Visceral Leishmaniasis in Brazil

1996 • 165 citations

Epidemic Visceral Leishmaniasis in Southern Sudan: Treatment of Severely Debilitated Patients under Wartime Conditions and with Limited Resources

1996 • 130 citations

A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate.

1998 • 126 citations

Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.

2001 • 124 citations

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome

2001 • 123 citations

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B

1999 • 121 citations

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

1992 • 114 citations

Practical Guide for the Treatment of Leishmaniasis

1998 • 112 citations

Socio-economics of visceral leishmaniasis in Bihar (India)

2000 • 108 citations

A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis

2000 • 106 citations

Visceral leishmaniasis in HIV infected patients: Treatment with high dose liposomal amphotericin B (AmBisome)

1996 • 101 citations

Role of PCR in Diagnosis and Prognosis of Visceral Leishmaniasis in Patients Coinfected with Human Immunodeficiency Virus Type 1

2001 • 98 citations

Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya

1982 • 97 citations

Oral treatment of visceral leishmaniasis with miltefosine

1999 • 94 citations

Phase 2 Efficacy Trial of an Oral 8-Aminoquinoline (WR6026) for Treatment of Visceral Leishmaniasis

1994 • 93 citations

Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India

1992 • 91 citations

HIV-associated visceral leishmaniasis

2001 • 86 citations

A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan

2000 • 83 citations

Operational validation of the direct agglutination test for diagnosis of visceral leishmaniasis.

1999 • 80 citations

Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study

2000 • 69 citations

Visceral leishmaniasis unresponsive to antimonial drugs I. Clinical and immunological studies

1985 • 68 citations

Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom

1992 • 67 citations

Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial

1995 • 65 citations

Investigation of the spread of human visceral leishmaniasis in central Tunisia

2000 • 64 citations

Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.

2001 • 57 citations

Endemic disease and development: the leishmaniases

1994 • 56 citations

Protective efficacy of lambdacyhalothrin‐impregnated bednets against Phlebotomus orientalis, the vector of visceral leishmaniasis in Sudan

1999 • 53 citations

Short Report: Detection of 72–75-kD and 123-kD Fractions of Leishmania Antigen in Urine of Patients with Visceral Leishmaniasis

1995 • 52 citations

Polymerase Chain Reaction in the Diagnosis and Prognosis of Mediterranean Visceral Leishmaniasis in Immunocompetent Children

2002 • 51 citations

Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis.

1999 • 47 citations

Multi‐centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis

1999 • 46 citations

Evaluation of the direct agglutination test (DAT) using freeze-dried antigen for the detection of anti-Leishmania antibodies in stored sera from various patient groups in Ethiopia

1999 • 42 citations

Comparison of regimens of amphotericin B deoxycholate in kala-azar.

1996 • 34 citations

Influence of Highly Active Antiretroviral Therapy on the Outcome of Subclinical Visceral Leishmaniasis in Human Immunodeficiency Virus-Infected Patients

2001 • 34 citations

Current issues in the treatment of visceral leishmaniasis

2001 • 27 citations

Advances in the Therapeutics of Antimony

1938 • 23 citations

Developments in the treatment of leishmaniasis and trypanosomiasis

2002 • 18 citations

Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.

1999 • 17 citations

Treatment of Visceral Leishmaniasis with Amphotericin B Colloidal Dispersion

1999 • 13 citations

Laboratory evaluation of lambda-cyhalothrin a microencapsulated formulation on mosquito nets for control of vector mosquitos.

1999 • 12 citations

Visceral leishmaniasis control in India through primary health care system--a successful experiment of district level planning.

1996 • 6 citations

Direct agglutination test for early diagnosis of Indian visceral leishmaniasis.

1996 • 3 citations